RESEARCH PAPER
Epidemiology of sarcoidosis recorded in 2006–2010 in the Silesian voivodeship on the basis of routine medical reporting
 
More details
Hide details
1
Department of Epidemiology, Medical Faculty, Medical University of Silesia, Katowice, Poland
2
Medical University of Silesia, Katowice, Poland
 
Ann Agric Environ Med. 2014;21(1):55–58
KEYWORDS
ABSTRACT
Introduction and objective. The incidence of sarcoidosis (D.86.0, D.86.2) varies worldwide, although published data suggest that the rate remains at the level 10–40/100 000 population. In Poland, statistics are not conducted on sarcoidosis. The etiology of the disease remains unclear, but researchers suggest that one of causes is the exposure to environmental factors. The aim of this study is to determine territorial and temporal variations of incidence and hospitalized prevalence of sarcoidosis for adults aged 19 and older living in the Silesian voivodeship in south-western Poland. Materials and methods. To identify the number of cases of sarcoidosis and the number of hospitalized patients in 2006–2010, the database of the National Health Fund in Katowice, Silesia, was used. Data related to adults aged 19 and older who were inhabitants of the Silesian voivodeship. Standardized incidence and prevalence rates for total sarcoidosis per 100,000 population were calculated using the world standard population. Temporal and spatial variability of both rates in the Silesian voivodeship were presented according to ArcGIS 9.2. Results. The number of new cases of sarcoidosis is still increasing. The disease occurred primarily in younger men (25–50 years of age), as well as in some older women (age group 50–64 years). Standardized incidence rates of total sarcoidosis are in the range 3.8–4.5/100,000 population. There was a probable relationship between the incidence of sarcoidosis and the area of forest (r=0.4) or arable land (r=0.3). Conclusions. Sarcoidosis is a rare disease in the Silesian voivodeship and the standardized incidence and prevalence rates are slightly higher in men than in women. In the study period, spatial variability was observed. The highest rates were typical for districts with a predominance of forests and arable land.
 
REFERENCES (14)
1.
Komisja Chorób Układu Oddechowego Komitetu Patofizjologii Klinicznej PAN. Choroby śródmiąższowe płuc. Skala problemu – trudności diagnostyczne. www.kompat.pan.pl/images/stori... pdf/wytyczneopinie/choroby_ srodmiazszowe.pdf (access: 21.02.2013) (in Polish).
 
2.
Szafrański W. Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000–2009. Pneumonol Alergol Pol. 2012; 80(6): 523–532 (in Polish).
 
3.
Płodziszewska M, Wiatr E. Sarkoidoza. W: Wiatr E, RowińskaZakrzewska E, Pirożyński M. Choroby śródmiąższowe płuc. Alfamedica Press, Warszawa 2012.p.111–116 (in Polish).
 
4.
Ziora D, Jastrzębski D, Labus Ł. Advances in diagnosis of pulmonary sarcoidosis. Pneumonol Alergol Pol. 2012; 80(4): 355–364 (in Polish).
 
5.
Gerke AK, Yang M, Tang F, Cavanaugh JE, Polgreen PM. Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study. BMC Pulm Med. 2012; 12: 19.
 
6.
Saadoun D, Wechsler B. Behçet’s disease. J Bras Pneumol.Orphanet J Rare Dis. 2012; 7: 20.
 
7.
Lemos-Silva V, Araújo PB, Lopes C, Rufino R, da Costa CH. Epidemiological characteristics of sarcoidosis patients in the city of Rio de Janeiro, Brazil. J Bras Pneumol. 2011; 37(4): 438–445.
 
8.
American Thoracic Society. Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999; 160: 736–755.
 
9.
Rybicki BA, Maliarik MJ, Poisson LM, Iannuzzi MC. Sarcoidosis and granuloma genes: a family-based study in African-Americans; Eur Respir J. 2004; 24(2): 251–257.
 
10.
Goljan A, Puścińska E, Zych D, Zieliński J. Sarkoidoza Familial sarcoidosis in Poland: Clinical characteristics and environmental aspects; Pneumonol Alergol Pol. 2000; 68(11–12): 510–522.
 
11.
Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004; 170(12): 1324–1330.
 
12.
International Statistical Classification of Diseases and Related Health Problems (ICD-10). www.icd10.pl (access: 21.02.2013).
 
13.
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a New WHO standard. GPE Discussion Paper Series: No 31, EIP/GPE/EBD, 2001.
 
14.
www.who.int/healthinfo/ paper31.pdf (access: 21.02.2013). 14. Local Data Bank, Central Statistical Office. www.stat.gov.pl/gus (access: 21.02.2013) (in Polish).
 
eISSN:1898-2263
ISSN:1232-1966